Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases TD Hollingsworth, ER Adams, RM Anderson, K Atkins, S Bartsch, ... Parasites & vectors 8, 1-28, 2015 | 103 | 2015 |
Between-country inequalities in the neglected tropical disease burden in 1990 and 2010, with projections for 2020 WA Stolk, MC Kulik, EA le Rutte, J Jacobson, JH Richardus, SJ de Vlas, ... PLoS neglected tropical diseases 10 (5), e0004560, 2016 | 83 | 2016 |
Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained? SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ... PLoS neglected tropical diseases 10 (2), e0004386, 2016 | 79 | 2016 |
Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation J Toor, ER Adams, M Aliee, B Amoah, RM Anderson, D Ayabina, R Bailey, ... Clinical Infectious Diseases 72 (8), 1463-1466, 2021 | 74 | 2021 |
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland AJ Shattock, EA Le Rutte, RP Dünner, S Sen, SL Kelly, N Chitnis, ... Epidemics 38, 100535, 2022 | 59 | 2022 |
Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models EA Le Rutte, LAC Chapman, LE Coffeng, S Jervis, EC Hasker, S Dwivedi, ... Epidemics 18, 67-80, 2017 | 58* | 2017 |
Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India S Jervis, LAC Chapman, S Dwivedi, M Karthick, A Das, EA Le Rutte, ... Parasites & vectors 10, 1-17, 2017 | 56 | 2017 |
Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models EA Le Rutte, LE Coffeng, DM Bontje, EC Hasker, JA Ruiz Postigo, ... Parasites & vectors 9, 1-14, 2016 | 54 | 2016 |
Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management … EJ Lenk, WK Redekop, M Luyendijk, C Fitzpatrick, L Niessen, WA Stolk, ... PLoS neglected tropical diseases 12 (3), e0006250, 2018 | 53 | 2018 |
Post-kala-azar dermal leishmaniasis as a reservoir for visceral leishmaniasis transmission EA Le Rutte, EE Zijlstra, SJ de Vlas Trends in parasitology 35 (8), 590-592, 2019 | 52 | 2019 |
Policy recommendations from transmission modeling for the elimination of visceral leishmaniasis in the Indian subcontinent EA Le Rutte, LAC Chapman, LE Coffeng, JA Ruiz-Postigo, PL Olliaro, ... Clinical Infectious Diseases 66 (suppl_4), S301-S308, 2018 | 41 | 2018 |
Uniting mathematics and biology for control of visceral leishmaniasis KS Rock, EA le Rutte, SJ de Vlas, ER Adams, GF Medley, ... Trends in parasitology 31 (6), 251-259, 2015 | 39 | 2015 |
Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey K Cloots, S Uranw, B Ostyn, NR Bhattarai, E Le Rutte, B Khanal, A Picado, ... The Lancet Global Health 8 (2), e237-e243, 2020 | 37 | 2020 |
Awareness and control of canine leishmaniosis: a survey among Spanish and French veterinarians EA Le Rutte, R van Straten, PAM Overgaauw Veterinary parasitology 253, 87-93, 2018 | 36 | 2018 |
Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India CA Bulstra, EA Le Rutte, P Malaviya, EC Hasker, LE Coffeng, A Picado, ... PLoS Neglected Tropical Diseases 12 (12), e0006888, 2018 | 34 | 2018 |
Human leishmaniasis vaccines: Use cases, target population and potential global demand S Malvolti, M Malhame, CF Mantel, EA Le Rutte, PM Kaye PLoS Neglected Tropical Diseases 15 (9), e0009742, 2021 | 33 | 2021 |
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden EA Le Rutte, AJ Shattock, N Chitnis, SL Kelly, MA Penny Communications Medicine 2 (1), 93, 2022 | 29* | 2022 |
Overcoming roadblocks in the development of vaccines for leishmaniasis PM Kaye, S Mohan, C Mantel, M Malhame, P Revill, E Le Rutte, ... Expert Review of Vaccines 20 (11), 1419-1430, 2021 | 26 | 2021 |
Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India EA Le Rutte, LE Coffeng, J Muñoz, SJ de Vlas Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (3 …, 2021 | 26 | 2021 |
The potential impact of human visceral leishmaniasis vaccines on population incidence EA Le Rutte, LE Coffeng, S Malvolti, PM Kaye, SJ de Vlas PLoS neglected tropical diseases 14 (7), e0008468, 2020 | 24 | 2020 |